Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eloralintide in Adult Participants With Obesity or Overweight
NCT06230523Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2024
- Primary completion
- May 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of eloralintide in obesity, sponsored by Eli Lilly and Company. Started Feb 2024; status: completed.
02
Drugs
eloralintide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06230523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06230523.